CD4 and COVID-19: Thus, several studies have demonstrated that patients with severe COVID-19, when compared to patients with mild COVID-19, exhibit less robust CD4+ and CD8+ T cell responses against SARS-CoV-2 membrane, nucleocapsid, and spike proteins (47–49).